Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM8 | O00222 | 2/20 | 0.57 |
| ▸ | GRM6 | O15303 | 2/20 | 0.57 |
| ▸ | GRM7 | Q14831 | 2/20 | 0.57 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.57 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.57 |
| ▸ | GSR | P00390 | 2/20 | 0.57 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.57 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.57 |
| ▸ | GRM5 | P41594 | 1/20 | 0.57 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.57 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.57 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.57 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.57 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.57 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.57 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.57 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.57 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2263158 | 1.00 | GRM8 (0.57) | GRM8GRM6GRM7GRM4SLC1A1 | |
| Succinic Acid SCHEMBL30975323 | 1.00 | GRM8 (0.57) | GRM8GRM6GRM7GRM4SLC1A1 | |
| SCHEMBL30670174 | 0.89 | GRM8 (0.53) | GRM8GRM6GRM7GRM4SLC1A1 | |
| SCHEMBL29714734 | 0.87 | BHMT (0.54) | GRM8GRM6GRM7GRM4SLC1A1 | |
| SCHEMBL11075958 | 0.85 | GRM8 (0.63) | GRM8GRM6GRM7GRM4SLC1A1 | |
| SCHEMBL21531606 | 0.82 | SLC1A1 (0.48) | GRM8GRM6GRM7GRM4SLC1A1 | |
| Glutamic Acid SCHEMBL19348257 | 0.80 | GRM8 (0.62) | GRM8GRM6GRM7GRM4SLC1A1 | |
| SCHEMBL7991509 | 0.80 | GRM8 (0.50) | GRM8GRM6GRM7GRM4SLC1A1 | |
| SCHEMBL7931451 | 0.78 | GRM8 (0.65) | GRM8GRM6GRM7GRM4SLC1A1 | |
| SCHEMBL6425120 | 0.78 | CYP2C19 (0.44) | GRM8GRM6GRM7GRM4SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 517 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122081132-A | Lactobacillus johnsonii DA0207 and application thereof in periplaneta americana fermentation | — | 2026-05-26 | — | — | CN | claimed |
| US-20260002183-A1 | ENZYMATIC METHOD FOR PRODUCING L-GLUFOSINATE AND ITS PHOSPHOESTERS | EVONIK OPERATIONS GMBH (DE) | 2026-01-01 | — | — | US | claimed |
| EP-4590846-A1 | ENZYMATIC METHOD FOR PRODUCING L-GLUFOSINATE AND ITS PHOSPHOESTERS | Evonik Operations GmbH (DE) | 2025-07-30 | — | — | EP | claimed |
| EP-3909962-B1 | METHOD OF PRODUCING L-GLUFOSINATE | CJ CHEILJEDANG CORP (KR) | 2025-05-21 | — | — | EP | claimed |
| CN-119907861-A | Enzymatic catalytic process for the production of L-glufosinate and its phosphate | 赢创运营有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-119788283-A | Differential privacy-based double-round privacy protection method | 北京理工大学 | 2025-04-08 | — | — | CN | claimed |
| EP-4341933-B1 | OUTPUT CIRCUIT FOR ANALOG NEURAL MEMORY IN A DEEP LEARNING ARTIFICIAL NEURAL NETWORK | SILICON STORAGE TECH INC (US) | 2025-03-19 | — | — | EP | claimed |
| CN-118977616-B | Unmanned mining truck charging management method | 中铁十九局集团矿业投资有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119372125-A | Engineering escherichia coli for producing O-succinyl-L-homoserine as well as construction method and application thereof | 浙江工业大学 | 2025-01-28 | — | — | CN | claimed |
| CN-118374391-B | Escherichia coli with high O-succinyl-L-homoserine yield obtained by utilizing adaptive evolution screening | 杭州优泽生物科技有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-115896087-A | Sulfydryl lyase-PLP co-immobilized enzyme and application thereof | 浙江工业大学 | 2023-04-04 | — | — | CN | claimed |
| EP-4152171-A1 | A PROCESSING SYSTEM COMPRISING A QUEUED SERIAL PERIPHERAL INTERFACE, RELATED INTEGRATED CIRCUIT, DEVICE AND METHOD | STMicroelectronics Application GmbH (DE) | 2023-03-22 | — | — | EP | claimed |
| EP-3885924-B1 | A PROCESSING SYSTEM COMPRISING A QUEUED SERIAL PERIPHERAL INTERFACE, RELATED INTEGRATED CIRCUIT, DEVICE AND METHOD | STMICROELECTRONICS APPLICATION GMBH (DE) | 2023-01-04 | — | — | EP | claimed |
| WO-2022207543-A1 | ENZYMATIC METHOD FOR PRODUCING L-GLUFOSINATE AND ITS PHOSPHOESTERS | EVONIK OPERATIONS GMBH (DE) | 2022-10-06 | — | — | WO | claimed |
| CN-108026550-B | Process for the preparation of L-methionine | 阿肯马法国公司 | 2022-10-04 | — | — | CN | claimed |
| CN-115005122-A | Tease pet device | 深圳市金钢人科技有限公司 | 2022-09-06 | — | — | CN | claimed |
| WO-2022117951-A1 | METHOD FOR SYNTHESISING FUNCTIONALISED MERCAPTANS UNDER H2S PRESSURE | ARKEMA FRANCE (FR) | 2022-06-09 | — | — | WO | claimed |
| EP-3325985-B1 | DEVICE FOR ELECTROMAGNETIC DOSIMETRY AND ASSOCIATED METHOD | UNIV RENNES (FR) | 2022-04-06 | — | — | EP | claimed |
| CN-108603206-B | Bio-based N-acetyl-L-methionine and uses thereof | CJ第一制糖株式会社 | 2022-03-18 | — | — | CN | claimed |
| EP-3966461-A1 | THREADED POSITIONING MECHANISM | XR Downhole, LLC (US) | 2022-03-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260002183-A1 | ENZYMATIC METHOD FOR PRODUCING L-GLUFOSINATE AND ITS PHOSPHOESTERS | PGLS, GLO1, GLUL | GRM8 1489/4885GRM6 1077/4885GRM7 2059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.